Board approves allotment of 1,00,00,000 unlisted NCRPS under First Tranche
Chemiesynth (Vapi) Ltd's Board met on Wednesday, 28th October, 2026 and approved allotment of Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis under the First Tranche.
By ScoutQuest · · 2 min read
- NCRPS Allotted
- 1,00,00,000 NCRPS at ₹10 each, aggregating ₹10 crore
- Dividend Rate
- 5% cumulative dividend per annum
- Tenure / Terms
- 7-year tenure, unsecured with no charge on company assets; call and put options after 2 years
Board meeting outcome
The Board of Directors, at its meeting held on Wednesday, 28th October, 2026, considered and approved the allotment of Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis under the First Tranche, pursuant to the approval of the members of the Company and receipt of subscription money. The Board also authorised the necessary statutory updates and consequential actions for the allotment.
What was allotted
- Type of security: Non-Convertible Cumulative Redeemable Preference Shares (NCRPS)
- Number allotted: 1,00,00,000 in the First Tranche
- Face value: ₹10 per share
- Issue price: ₹10 at par, as per the valuation report
- Aggregate size of the issue: ₹10 crore
- Listing: the NCRPS are unlisted
Key terms
- Dividend: 5% cumulative per annum, payable in accordance with the terms of issue and applicable law
- Tenure: 7 years from allotment; date of allotment 28-10-2026, date of maturity 28-10-2033
- Company call option and investor put option may be exercisable after 2 years, subject to the terms of issue and 30 days' notice
- Redemption: at the expiry of 7 years from the date of allotment, subject to applicable law and the terms of issue
- Security: the NCRPS are unsecured and do not carry any charge on the assets of the Company
How to read this
- Preference shares rank ahead of equity shares for dividend and for repayment in case of winding up or repayment of capital. That is the preferential right attached to this instrument.
- The instrument is non-convertible, so these shares do not turn into equity shares.
- Because the NCRPS are unsecured, they do not have a charge over the Company's assets behind them.
- The shares are being issued on a private placement basis, so they are allotted to specific investors rather than to the public, and they will not be listed on an exchange.
- The update marks the delay or default in payment of interest or principal, and related comments, as "Not applicable".
Also from Chemiesynth (Vapi)
Board meeting on 04 November 2026 to consider unaudited results for September quarter
30 Oct 2026
Board approves allotment of 1,00,00,000 unlisted NCRPS on private placement basis
28 Oct 2026
Board meeting on 28 October 2026 to consider allotment of unlisted NCRPS on private placement
23 Oct 2026
More numbers
- NCRPS allotted in First Tranche1,00,00,000 in First Tranche
- Face value per NCRPS₹10 per share
- Issue price per NCRPS₹10 at par as per valuation report
- Aggregate size of the issue₹10,00,00,000
- Dividend rate5% cumulative per annum
- Tenure of the instrument7 years from allotment
- Call and put option exercisable afterafter 2 years
- Notice period for options30 days' notice
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.